Skip to main content
. 2022 Feb 25;101(8):e28823. doi: 10.1097/MD.0000000000028823

Table 1.

Number of patients before and after matching for each drug comparison and HbA1c outcome.

JNUH KNUH PNUH
Unmatched Matched Unmatched Matched Unmatched Matched
Oral hypoglycemic agents T C T C T C T C T C T C
Metformin (T) vs SU (C) 1542 1147 1147 1147 1026 556 556 556 1622 243 243 243
Metformin (T) vs DPP4I (C) 1542 745 721 721 1147 745 702 702 1026 489 484 484
SU (T) vs DPP4I (C) 1147 745 702 702 556 489 461 461 243 293 226 226
Metformin + DPP4I (T) vs Metformin + SU (C) 402 247 241 241 331 169 169 169 597 328 328 328
Metformin + DPP4I (T) vs SU + DPP4I (C) 402 60 60 60 331 35 35 35 597 49 49 49
Metformin + SU (T) vs SU + DPP4I (C) 247 60 56 56 169 35 35 35 328 49 49 49

C = comparator, DPP4I = dipeptidyl peptidase-4 inhibitors, HbA1c = glycosylated hemoglobin, JNUH = Jeonbuk National University Hospital, KNUH = Kangwon National University Hospital, PNUH = Pusan National University Hospital, SU = sulfonylurea, T = target.

Propensity score matching covariates: sex, age.